Table 9.
Syndromes associated with vascular anomalies.
Syndrome | Clinical phenotype | Candidate gene | Protein function or suspected role (if known) | Clinical work-up | References |
---|---|---|---|---|---|
CLOVES syndrome | • Characterized by congenital lipomatous overgrowth • Vascular malformations • Epidermal nevi • Skeletal anomalies |
PIK3CA, due to mosaic or missense mutations | • Catalytic alpha subunit of PI3K. Somatic activating mutation that increases PI3K/AKT/mTOR signaling | • Brain MRI • X-rays for leg length discrepancy • Scoliosis screen • Echocardiogram • EEG • Renal US to rule out anomalies and q3-6 months to screen for Wilms tumor • Screening for paraspinal high-flow lesions with spinal cord ischemia • Thrombophilia evaluation • Developmental • Feeding assessment |
(3, 15) |
Klippel-Trenaunay syndrome | • Characterized by slow-flow capillary-lymphatic-venous malformations and soft tissue overgrowth of an extremity and/or trunk • Often involves the pelvis as well. Can be unilateral or bilateral |
PIK3CA, some cases AGGF1 |
• Catalytic alpha subunit of PI3K. Somatic activating mutation that increases PI3K/AKT/mTOR signaling • Angiogenic factor with G patch and FHA domains, increases angiogenesis in vitro |
• MRI imaging of affected area • Thrombophilia evaluation and labs for localized intravascular coagulation |
(3, 15) |
Megalencephaly-capillary malformation syndrome (MCAP) | • Congenital megalencephaly or hemimegalencephaly • Reticulate capillary stains • CM of the lip/philtrum • Asymmetry, focal, or generalized overgrowth • Hypotonia • Seizures • Mild to severe intellectual disability • Syndactyly |
PIK3CA, from brain tissue | • Catalytic alpha subunit of PI3K. Somatic activating mutation that increases PI3K/AKT/mTOR signaling | • Brain MRI q 6 months for the first 2 years then yearly till 8 years to rule out neurological complications • X-rays for leg length discrepancy • Scoliosis screen • EEG • Echocardiogram • Renal US to rule out anomalies and q 3 months to screen for Wilms tumor • Developmental and feeding assessment • Sleep evaluation • Thrombophilia evaluation |
(3, 10, 15) |
Maffucci syndrome | • Multiple spindle cell hemangiomas associated with multiple enchondromas • Vascular lesions often do not appear until puberty • Patients have increased risk for malignancy |
IDH1 and IDH2 | • Mutant enzymes catalyze the reduction of alfa-ketoglutarate to D-2-hydroxyglutarate, cause downstream genomic hypermethylation | • Screening of lesions due to malignancy potential • Risk of many types of malignancy reported (chondrosarcomas, gliomas, ovarian tumors, and other sarcomas) • Limb length x-rays and imaging of the extremities for other malformations |
(3, 10, 60) |
Proteus syndrome | • Bony and soft tissue overgrowth that develops and progresses rapidly in the toddler period and tends to plateau after adolescence • Increased risk of malignancy • Pulmonary complications • Increased risk thrombus |
AKT1 | • Intracellular PI3K/AKT/mTOR signaling/apoptosis | • Scoliosis screen • Skin exam • Thrombophilia evaluation and monitoring for DVT and PE • Developmental assessment • Monitoring for bullous pulmonary disease |
(3, 10, 11) |
Parkes weber syndrome | • Similar to CM-AVM but with overgrowth of affected limb | RASA1, loss of function mutation | • Intracellular signaling, RasGTPase | • Brain/spine MRI • US shows fast-flow lesion |
(3, 9, 11, 15) |
Familial intraosseous vascular malformation | • Extensive vascular lesions in the intraosseus spaces of the craniofacial bones associated with other midline defects • AR inheritance • Intraosseous hemangioma often in the vertebral column or the skull • Most commonly affected bones are the mandible and the maxilla • Life threatening progressive expansion of the jaw • Craniofacial and other intramembranous bones caused by malformed blood vessels |
ELMO2 | • Translation of extracellular signals to cellular movements | • MRI head and neck • Midline screen to look for diastasis recti, supraumbilical raphe and hiatal hernia |
(3, 61) |